Summer 2023 Vol. 13 Issue 02
-
From the Editor-in-Chief
Artificial IntelligenceAI has significant implications for medicine, especially for precision cancer care.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
A Difficult DuoPeople with cancer who have existing mental health conditions may need to double down to get the support they need.
by Hester Hill Schnipper
-
Caregiving With Confidence
Cancer ConfidentialCaregivers and their loved ones may need to set ground rules for communicating sensitive health information.
by K.J. Bannan
-
Policy Matters
Reigniting the MoonshotPresident Biden proposes increased investment in cancer research and prevention to achieve the goals of the revised Cancer Moonshot.
by Roy S. Herbst, MD, PhD
-
Getting Over Weight
Messages about weight are common in the U.S. Stigmatizing cancer patients because of their weight can negatively affect them in a health care setting.
by Eric Fitzsimmons
-
Ovarian Cancer: A Quest to Extend Remissions
New treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
-
ADCs Make Their Mark
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Survivor Profile
Educator and AdvocateFormer teacher Peggy Zuckerman helps others by sharing her experiences with stage IV kidney cancer.
by Kristin Baird Rattini
-
Q&A
Cancer’s Public PersonaElaine Schattner explores how public discourse has shaped our perception of cancer.
by Marci A Landsmann
-
Get Involved
Baked GoodnessSyreeta Harrison sells homemade cupcakes to fund care packages for people with cancer.
by Thomas Celona
-
Facts and Stats
Know the LingoMedical paperwork can be full of confusing jargon. Use these definitions to better understand the terms found in your pathology report.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin